AIM ImmunoTech Inc (NYSE American:AIM)
| 0.4525 BATS BZX Real-Time Price As of Jun 01 |  +0.0045 / +1.00%Today’s Change | 0.29 Today|||52-Week Range 1.05 | +45.08% Year-to-Date |
Latest AIM News | Press Releases
No recent news for AIM ImmunoTech Inc.
Today’s Trading
| Previous close | 0.45 |
| Today’s open | 0.45 |
| Day’s range | 0.45 - 0.45 |
| Volume | 14,070 |
| Average volume (3 months) | 120,946 |
| Market cap | $23.5M |
Data as of 3:56pm ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | -0.17% |
| Earnings growth (this year) | -5.00% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +4.44% |
| P/E ratio | NM |
| Price/Sales | 106.28 |
| Price/Book | 0.62 |
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $141.0K |
| Annual profit (last year) | -$19.4M |
| Net profit margin | -13,790.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Ocala, Florida |
Forecasts
